Peter Lichtlen
10Patents
2h-index
7Co-inventors
43Inventor score
Filing activity: Jun 6, 2006 → Mar 8, 2016
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8067547B2 | Stable and soluble antibodies inhibiting TNFα | Chemistry; Metallurgy | 15 | Active |
| US7902340B2 | Antibodies binding to the extracellular domain of the receptor tyrosine kinase ALK | Chemistry; Metallurgy | 6 | Active |
| US8945563B2 | Method for treating glioblastoma using antibodies binding to the extracellular domain of the receptor tyrosine kinase ALK | Chemistry; Metallurgy | 2 | Active |
| US9683034B2 | Stable and soluble antibodies inhibiting TNFα | Chemistry; Metallurgy | 2 | Active |
| US9315572B2 | Stable and soluble antibodies inhibiting TNF alpha | Chemistry; Metallurgy | 0 | Active |
| US8936785B2 | scFv antibodies which pass epithelial and/or endothelial layers | Chemistry; Metallurgy | 0 | Active |
| US8835571B2 | Fatty acid derivative-polymer conjugate | Human Necessities | 0 | Active |
| US8691228B2 | Stable and soluble antibodies inhibiting TNFα | Chemistry; Metallurgy | 0 | Active |
| US9512411B2 | Nucleic acid encoding antibodies binding to the extracellular domain of the receptor tyrosine kinase ALK | Chemistry; Metallurgy | 0 | Active |
| US8389693B2 | Stable and soluble antibodies inhibiting TNFα | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.